clinical partnering, clinical, partnering, clinical trials, clinical outsourcing, outsourcing, clinical outsourcing and partnering world europe

Download: 10 Key Insights on Clinical Partnering

This is the year we can increase the efficiencies of clinical trials through collaboration, innovation and enhancing quality. It is time to take stock on previous partnerships, current projects and future alliances. Where are the opportunities? How can we work differently with our partners? How can we embrace the changing technologies? How can we sustain effective clinical partnerships? These are crucial questions and ones …

Been a Partner? What’s Your #PartneringPetPeeve?

In the Pharmaceutical and Biotech industries, partnering and collaborations are a frequent occurrence. Usually, a larger company will utilize a more niche company as a partner for a specific function (CROs and CMOs), or find a smaller drug discovery company that has a compound of interest. This is particularly true in the Orphan Drug industry, where small pharma companies are …

Sun Pharma to acquire Ranbaxy

Sun Pharmaceutical Industries and Ranbaxy Laboratories have recently made an agreement to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction, meaning that Sun Pharma has effectively acquired Ranbaxy, a major player in Indian and US markets. Due to this acquisition, it creates the fifth-largest specialty generics company in the world and the largest pharmaceutical company in …

India’s Lupin queues up for a share of the biosimilar boom

Lupin is searching for partners to help bring it into the biosimilars market, aiming top-selling treatments with patents that are expiring soon. It already has 10 biosimilars products in development, with 5 in late-stage studies. Thus, it is looking for partners to help bring these products into the market. In addition to injectables for cancer and inflammatory disease, Lupin is …

Download Commercializing through collaboration: what does partnering in the stem cells industry really look like?

Download this presentation here > The 9th World Stem Cells & Regenerative Medicine Congress is Europe’s leading scientific and business development event for the stem cell and cell therapy industry. At the 2013 event, delegates were fortunate enough to hear from Ed Field, Chief Operating Officer, Cytomedix who delivered the presentation: ‘Commercializing through collaboration: what does partnering in this industry really …

Teva’s New CEO Moves Quickly on Dealmaking

Recently, pharmaceutical company Teva has been facing numerous challenges. These include expiring patents for their top drugs, strong labour opposition to plans for restructuring, conflict between the Board of Directors and Management which resulted in the CEO’s departure, and shareholder unrest. Eyal Desheh, the CFO, has said that they have to make smart deals and partnerships like how Teva has …

eBook: Top 10 Novel Clinical Alliances

Outsourcing is a commonplace tool used in the clinical environment. Despite the multiple benefits that it can and does offer and the integral role in many clinical trials there are many associated challenges and problems with traditional outsourcing. So it's time to look at new partnering opportunities, novel collaborations and better outsourcing practices. We want to highlight those companies that …

Download presentation- How are larger organizations viewing small biotech as innovative developers?

In November 2012 over 250 delegates participated in the 3rd Annual World Orphan Drug Congress Europe. This event covers strategies and opportunities from Clinical Development and R&D, Market Access, Pricing & Reimbursement , Corporate Development and Drug Repositioning & Indication Expansion. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Jeannie Joughin, VP …

Download: eBook ‘Top tips for successful commercialisation and scalable manufacture of cell therapies’

Bringing breakthrough therapies to market: 2013 is the year for regenerative medicine Think you know all the unique aspects to successfully commercialise your stem cell-based therapy? To announce the release to the 2013 World Stem Cells & Regenerative Medicine Congress brochure, we have also produced an eBook that provide an exclusive sneak-preview of the industry shaping content set to be …